Key facts
- Jiudian Nuona’s last known valuation is $65.5M (Dec 2025).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for Jiudian Nuona
- ·The full record, as it builds
Funding rounds
No funding rounds for Jiudian Nuona are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jiudian Nuona
Developer and manufacturer of pharmaceutical excipients intended for use in pharmaceuticals, biologics, and medical devices. The company provides research, technology transfer, and consulting services, enabling healthcare and life sciences organizations to advance product development and innovation.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2021
- Ownership
- Acquired/Merged (Operating Subsidiary)
Jiudian Nuona doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jiudian Nuona shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jiudian Nuona in its N-PORT filings yet. We sweep new filings monthly.